

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 4.89433264 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.89433264 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.89433264 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.89433264 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.89433264 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.89433264 |
| 7 | axon ensheathment in central nervous system (GO:0032291) | 4.30186470 |
| 8 | central nervous system myelination (GO:0022010) | 4.30186470 |
| 9 | response to pheromone (GO:0019236) | 4.14874596 |
| 10 | microglial cell activation (GO:0001774) | 4.08847213 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.05075052 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.04034421 |
| 13 | estrogen biosynthetic process (GO:0006703) | 3.79998095 |
| 14 | behavioral response to nicotine (GO:0035095) | 3.59180540 |
| 15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.57704789 |
| 16 | response to host immune response (GO:0052572) | 3.57704789 |
| 17 | gamma-aminobutyric acid transport (GO:0015812) | 3.55420351 |
| 18 | mannose metabolic process (GO:0006013) | 3.52744894 |
| 19 | neuronal action potential propagation (GO:0019227) | 3.38253110 |
| 20 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37801070 |
| 21 | response to host (GO:0075136) | 3.37801070 |
| 22 | response to host defenses (GO:0052200) | 3.37801070 |
| 23 | dendritic spine morphogenesis (GO:0060997) | 3.30811783 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.17246440 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.16479654 |
| 26 | postsynaptic membrane organization (GO:0001941) | 3.11086857 |
| 27 | macrophage activation (GO:0042116) | 3.09983719 |
| 28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.08119090 |
| 29 | membrane depolarization during action potential (GO:0086010) | 3.07372029 |
| 30 | apoptotic cell clearance (GO:0043277) | 2.99400091 |
| 31 | proline transport (GO:0015824) | 2.91460233 |
| 32 | neuromuscular process controlling posture (GO:0050884) | 2.85979857 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 2.82877557 |
| 34 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.82624654 |
| 35 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.82395711 |
| 36 | synaptic vesicle maturation (GO:0016188) | 2.79416806 |
| 37 | prostate gland growth (GO:0060736) | 2.77982902 |
| 38 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.77321103 |
| 39 | transmission of nerve impulse (GO:0019226) | 2.76992634 |
| 40 | regulation of neurotransmitter uptake (GO:0051580) | 2.76791459 |
| 41 | presynaptic membrane assembly (GO:0097105) | 2.74655335 |
| 42 | auditory behavior (GO:0031223) | 2.73045524 |
| 43 | L-amino acid import (GO:0043092) | 2.72538857 |
| 44 | serotonin metabolic process (GO:0042428) | 2.71926421 |
| 45 | presynaptic membrane organization (GO:0097090) | 2.71157358 |
| 46 | urinary tract smooth muscle contraction (GO:0014848) | 2.68481574 |
| 47 | primary amino compound metabolic process (GO:1901160) | 2.66028225 |
| 48 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.64111981 |
| 49 | regulation of synapse structural plasticity (GO:0051823) | 2.62272403 |
| 50 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.61651937 |
| 51 | startle response (GO:0001964) | 2.60690795 |
| 52 | glutamate receptor signaling pathway (GO:0007215) | 2.59905067 |
| 53 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.59493516 |
| 54 | negative regulation of granulocyte differentiation (GO:0030853) | 2.58044319 |
| 55 | cyclic nucleotide catabolic process (GO:0009214) | 2.56600931 |
| 56 | I-kappaB phosphorylation (GO:0007252) | 2.54524361 |
| 57 | regulation of respiratory system process (GO:0044065) | 2.53091443 |
| 58 | amino acid import (GO:0043090) | 2.53003343 |
| 59 | adaptation of signaling pathway (GO:0023058) | 2.51741412 |
| 60 | neuronal action potential (GO:0019228) | 2.51558680 |
| 61 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.51552540 |
| 62 | alanine transport (GO:0032328) | 2.49666306 |
| 63 | regulation of macrophage chemotaxis (GO:0010758) | 2.44765511 |
| 64 | vocalization behavior (GO:0071625) | 2.44198959 |
| 65 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.43862056 |
| 66 | keratan sulfate catabolic process (GO:0042340) | 2.43669239 |
| 67 | response to peptidoglycan (GO:0032494) | 2.43627753 |
| 68 | synaptic transmission, glutamatergic (GO:0035249) | 2.43499245 |
| 69 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42760480 |
| 70 | cortical actin cytoskeleton organization (GO:0030866) | 2.42549066 |
| 71 | potassium ion transmembrane transport (GO:0071805) | 2.41688240 |
| 72 | cellular potassium ion transport (GO:0071804) | 2.41688240 |
| 73 | cAMP catabolic process (GO:0006198) | 2.41681253 |
| 74 | neurotransmitter secretion (GO:0007269) | 2.41356209 |
| 75 | potassium ion import (GO:0010107) | 2.41059796 |
| 76 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.40792919 |
| 77 | relaxation of cardiac muscle (GO:0055119) | 2.39422864 |
| 78 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.39277642 |
| 79 | adhesion of symbiont to host cell (GO:0044650) | 2.38393832 |
| 80 | virion attachment to host cell (GO:0019062) | 2.38393832 |
| 81 | negative regulation of protein oligomerization (GO:0032460) | 2.36955135 |
| 82 | protein localization to cilium (GO:0061512) | 2.35614830 |
| 83 | cell adhesion mediated by integrin (GO:0033627) | 2.35326638 |
| 84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.34335717 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 2.34266159 |
| 86 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.34227398 |
| 87 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.33482791 |
| 88 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.32283640 |
| 89 | semaphorin-plexin signaling pathway (GO:0071526) | 2.31742108 |
| 90 | positive regulation of interferon-alpha production (GO:0032727) | 2.31693111 |
| 91 | potassium ion transport (GO:0006813) | 2.31517764 |
| 92 | neuron cell-cell adhesion (GO:0007158) | 2.30930402 |
| 93 | regulation of mononuclear cell migration (GO:0071675) | 2.30485177 |
| 94 | nephron tubule morphogenesis (GO:0072078) | 2.29239174 |
| 95 | nephron epithelium morphogenesis (GO:0072088) | 2.29239174 |
| 96 | positive regulation of antigen processing and presentation (GO:0002579) | 2.28114103 |
| 97 | neuron-neuron synaptic transmission (GO:0007270) | 2.27384525 |
| 98 | regulation of respiratory gaseous exchange (GO:0043576) | 2.27306864 |
| 99 | thyroid hormone metabolic process (GO:0042403) | 2.27086794 |
| 100 | membrane depolarization (GO:0051899) | 2.26942353 |
| 101 | detection of calcium ion (GO:0005513) | 2.26527191 |
| 102 | indole-containing compound metabolic process (GO:0042430) | 2.25297729 |
| 103 | neuromuscular synaptic transmission (GO:0007274) | 2.24810206 |
| 104 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.24562235 |
| 105 | negative regulation of cell killing (GO:0031342) | 2.23890889 |
| 106 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.23890889 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.23768149 |
| 108 | auditory receptor cell stereocilium organization (GO:0060088) | 2.23563032 |
| 109 | action potential (GO:0001508) | 2.23088599 |
| 110 | cortical cytoskeleton organization (GO:0030865) | 2.22122689 |
| 111 | response to lipoprotein particle (GO:0055094) | 2.21699154 |
| 112 | reflex (GO:0060004) | 2.21546584 |
| 113 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.21435218 |
| 114 | catecholamine transport (GO:0051937) | 2.21031500 |
| 115 | kidney morphogenesis (GO:0060993) | 2.19437648 |
| 116 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.19197683 |
| 117 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.19193346 |
| 118 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.19058473 |
| 119 | cochlea development (GO:0090102) | 2.18409772 |
| 120 | regulation of ARF protein signal transduction (GO:0032012) | 2.17361447 |
| 121 | substrate-dependent cell migration (GO:0006929) | 2.17250969 |
| 122 | glycosphingolipid biosynthetic process (GO:0006688) | 2.17159832 |
| 123 | sodium ion export (GO:0071436) | 2.16928525 |
| 124 | indole-containing compound catabolic process (GO:0042436) | 2.16864861 |
| 125 | indolalkylamine catabolic process (GO:0046218) | 2.16864861 |
| 126 | tryptophan catabolic process (GO:0006569) | 2.16864861 |
| 127 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.16767717 |
| 128 | glutamate secretion (GO:0014047) | 2.16644496 |
| 129 | parturition (GO:0007567) | 2.16469278 |
| 130 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.16331800 |
| 131 | glycerophospholipid catabolic process (GO:0046475) | 2.15674180 |
| 132 | relaxation of smooth muscle (GO:0044557) | 2.15564436 |
| 133 | negative regulation of astrocyte differentiation (GO:0048712) | 2.15391118 |
| 134 | regulation of action potential (GO:0098900) | 2.15202751 |
| 135 | indolalkylamine metabolic process (GO:0006586) | 2.15079159 |
| 136 | L-fucose metabolic process (GO:0042354) | 2.14930995 |
| 137 | L-fucose catabolic process (GO:0042355) | 2.14930995 |
| 138 | fucose catabolic process (GO:0019317) | 2.14930995 |
| 139 | regulation of interferon-alpha production (GO:0032647) | 2.14741126 |
| 140 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.14733608 |
| 141 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.14421873 |
| 142 | synaptic vesicle exocytosis (GO:0016079) | 2.14152826 |
| 143 | cellular ketone body metabolic process (GO:0046950) | 2.14027364 |
| 144 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.13887991 |
| 145 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.13424592 |
| 146 | phagocytosis, engulfment (GO:0006911) | 2.13245780 |
| 147 | protein localization to synapse (GO:0035418) | 2.12464502 |
| 148 | respiratory burst (GO:0045730) | 2.12082296 |
| 149 | regulation of mast cell degranulation (GO:0043304) | 2.11622586 |
| 150 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.10704169 |
| 151 | regulation of regulated secretory pathway (GO:1903305) | 2.10159754 |
| 152 | regulation of leukocyte degranulation (GO:0043300) | 2.08993935 |
| 153 | cellular extravasation (GO:0045123) | 2.08142702 |
| 154 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.07941165 |
| 155 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.07902635 |
| 156 | response to fluid shear stress (GO:0034405) | 2.07198335 |
| 157 | phagosome maturation (GO:0090382) | 2.07197412 |
| 158 | monocyte chemotaxis (GO:0002548) | 2.07004769 |
| 159 | response to muramyl dipeptide (GO:0032495) | 2.06783237 |
| 160 | G-protein coupled receptor internalization (GO:0002031) | 2.06407262 |
| 161 | activated T cell proliferation (GO:0050798) | 2.06052843 |
| 162 | protein localization to endosome (GO:0036010) | 2.05575900 |
| 163 | hyaluronan catabolic process (GO:0030214) | 2.05466377 |
| 164 | positive regulation of leukocyte degranulation (GO:0043302) | 2.04675501 |
| 165 | cellular potassium ion homeostasis (GO:0030007) | 2.03599257 |
| 166 | adhesion of symbiont to host (GO:0044406) | 2.03551467 |
| 167 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.02538779 |
| 168 | granulocyte activation (GO:0036230) | 2.02043598 |
| 169 | regulation of ARF GTPase activity (GO:0032312) | 2.01969627 |
| 170 | nerve growth factor signaling pathway (GO:0038180) | 2.00588572 |
| 171 | ruffle organization (GO:0031529) | 2.00139543 |
| 172 | lysosome organization (GO:0007040) | 2.00122449 |
| 173 | lytic vacuole organization (GO:0080171) | 2.00122449 |
| 174 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 1.99035870 |
| 175 | neutrophil activation (GO:0042119) | 1.97266090 |
| 176 | potassium ion homeostasis (GO:0055075) | 1.97125258 |
| 177 | positive regulation of mast cell activation (GO:0033005) | 1.96325228 |
| 178 | positive regulation of heat generation (GO:0031652) | 1.96242169 |
| 179 | chondroitin sulfate catabolic process (GO:0030207) | 1.96162585 |
| 180 | detection of molecule of bacterial origin (GO:0032490) | 1.95045568 |
| 181 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 1.94613538 |
| 182 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 1.94026692 |
| 183 | positive regulation of mast cell degranulation (GO:0043306) | 1.94026692 |
| 184 | negative regulation of interleukin-6 production (GO:0032715) | 1.93902293 |
| 185 | regulation of macrophage cytokine production (GO:0010935) | 1.92632954 |
| 186 | response to laminar fluid shear stress (GO:0034616) | 1.91104692 |
| 187 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 1.87747989 |
| 188 | positive regulation of regulated secretory pathway (GO:1903307) | 1.87211542 |
| 189 | locomotory exploration behavior (GO:0035641) | 1.87159129 |
| 190 | positive regulation of macrophage cytokine production (GO:0060907) | 1.87115184 |
| 191 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 1.86840504 |
| 192 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 1.86312607 |
| 193 | neutrophil mediated immunity (GO:0002446) | 1.85860809 |
| 194 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 1.85455051 |
| 195 | regulation of antigen processing and presentation (GO:0002577) | 1.84963035 |
| 196 | pinocytosis (GO:0006907) | 1.84795580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.87146826 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.69228535 |
| 3 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34294266 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.33818920 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30052218 |
| 6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.29125749 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.24338829 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05588562 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.98847505 |
| 10 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96992935 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96119157 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.94026793 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.88474979 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84221027 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.80389485 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80042602 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78923467 |
| 18 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.78701933 |
| 19 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77251666 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74691323 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69546040 |
| 22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68123713 |
| 23 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66887693 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.63612094 |
| 25 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.63387874 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59080276 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55630778 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55073282 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54196167 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53166914 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.53027604 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.52713010 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51691447 |
| 34 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50844880 |
| 35 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.50705545 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.47274159 |
| 37 | TP53_16413492_ChIP-PET_HCT116_Human | 1.47105422 |
| 38 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46805027 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45553147 |
| 40 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.44176909 |
| 41 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44083947 |
| 42 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.43534043 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43524972 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43291306 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43291306 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42708947 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42253679 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41934300 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40457430 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38341136 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.37193628 |
| 52 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.36806061 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.36681605 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35584375 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35357904 |
| 56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35171387 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.34644355 |
| 58 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34078227 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31732913 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31197119 |
| 61 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.31049334 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30643477 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30463187 |
| 64 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.29661995 |
| 65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.29429657 |
| 66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28354905 |
| 67 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28195169 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28069874 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26646242 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25168932 |
| 71 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25085403 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25062425 |
| 73 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24789219 |
| 74 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24789219 |
| 75 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.23884868 |
| 76 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23536173 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23154733 |
| 78 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22946150 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22658374 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22223280 |
| 81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21870065 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21770842 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21416434 |
| 84 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.20616516 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20010123 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19423013 |
| 87 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.18736461 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17391686 |
| 89 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.17287196 |
| 90 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17237319 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16565779 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16565779 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15011105 |
| 94 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14907964 |
| 95 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.14775025 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14712577 |
| 97 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13906270 |
| 98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13603658 |
| 99 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13374733 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12825622 |
| 101 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12350959 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12173988 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11524231 |
| 104 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10277160 |
| 105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09575166 |
| 106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09172813 |
| 107 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08683217 |
| 108 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08275334 |
| 109 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08256973 |
| 110 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08072168 |
| 111 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08070496 |
| 112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07675093 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07675093 |
| 114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07033475 |
| 115 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06693682 |
| 116 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.05975780 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05763031 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05118705 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05047204 |
| 120 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04612929 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04612051 |
| 122 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03912779 |
| 123 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03600434 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03299894 |
| 125 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03270444 |
| 126 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03118448 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03091103 |
| 128 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01820131 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01439040 |
| 130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00374592 |
| 131 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99539052 |
| 132 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99091048 |
| 133 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98356577 |
| 134 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98356577 |
| 135 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98114738 |
| 136 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98004811 |
| 137 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97720731 |
| 138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97505249 |
| 139 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96030778 |
| 140 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96009980 |
| 141 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95679571 |
| 142 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95459681 |
| 143 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.95437080 |
| 144 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.95382172 |
| 145 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95374404 |
| 146 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95070637 |
| 147 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95047365 |
| 148 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94468365 |
| 149 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94181898 |
| 150 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94181898 |
| 151 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93284530 |
| 152 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.92881019 |
| 153 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92730308 |
| 154 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92036222 |
| 155 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.91816227 |
| 156 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91286182 |
| 157 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91238707 |
| 158 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90263749 |
| 159 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89637081 |
| 160 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87833706 |
| 161 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86920327 |
| 162 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86878484 |
| 163 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85426995 |
| 164 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.84872299 |
| 165 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84639820 |
| 166 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84061335 |
| 167 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.83686379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.29294807 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.76772428 |
| 3 | MP0004510_myositis | 3.08940314 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.96715279 |
| 5 | MP0005257_abnormal_intraocular_pressure | 2.91761095 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.90197394 |
| 7 | MP0003880_abnormal_central_pattern | 2.82364707 |
| 8 | MP0009745_abnormal_behavioral_response | 2.72565944 |
| 9 | MP0003303_peritoneal_inflammation | 2.67540516 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.42083493 |
| 11 | MP0002272_abnormal_nervous_system | 2.41330620 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.39977058 |
| 13 | MP0004885_abnormal_endolymph | 2.36234503 |
| 14 | MP0003195_calcinosis | 2.35733727 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.32232550 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.23789942 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.19235193 |
| 18 | MP0003690_abnormal_glial_cell | 2.18853101 |
| 19 | MP0006276_abnormal_autonomic_nervous | 2.11100794 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.10905915 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.06662218 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.06544990 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.04418601 |
| 24 | MP0001486_abnormal_startle_reflex | 2.01315485 |
| 25 | MP0002090_abnormal_vision | 2.01196602 |
| 26 | MP0003136_yellow_coat_color | 1.95025761 |
| 27 | MP0006082_CNS_inflammation | 1.94594733 |
| 28 | MP0005310_abnormal_salivary_gland | 1.92717022 |
| 29 | MP0004084_abnormal_cardiac_muscle | 1.91477273 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.90012352 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.88926343 |
| 32 | MP0004142_abnormal_muscle_tone | 1.83880547 |
| 33 | MP0003279_aneurysm | 1.83614045 |
| 34 | MP0002653_abnormal_ependyma_morphology | 1.82007450 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 1.80346256 |
| 36 | MP0001970_abnormal_pain_threshold | 1.79984402 |
| 37 | MP0002419_abnormal_innate_immunity | 1.79326826 |
| 38 | MP0003045_fibrosis | 1.76517964 |
| 39 | MP0000343_altered_response_to | 1.71685785 |
| 40 | MP0002163_abnormal_gland_morphology | 1.71498458 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.70819373 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.70181783 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.66303090 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.63327023 |
| 45 | MP0003787_abnormal_imprinting | 1.61863073 |
| 46 | MP0004858_abnormal_nervous_system | 1.61597476 |
| 47 | MP0004043_abnormal_pH_regulation | 1.59846433 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.57235831 |
| 49 | MP0001984_abnormal_olfaction | 1.56956949 |
| 50 | MP0005423_abnormal_somatic_nervous | 1.56106724 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.55218259 |
| 52 | MP0003436_decreased_susceptibility_to | 1.55211571 |
| 53 | MP0003828_pulmonary_edema | 1.54942738 |
| 54 | MP0003283_abnormal_digestive_organ | 1.53884314 |
| 55 | MP0002734_abnormal_mechanical_nocicepti | 1.52701570 |
| 56 | MP0008872_abnormal_physiological_respon | 1.52666169 |
| 57 | MP0004742_abnormal_vestibular_system | 1.52344165 |
| 58 | MP0001485_abnormal_pinna_reflex | 1.51278720 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.51010239 |
| 60 | MP0002638_abnormal_pupillary_reflex | 1.49807778 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.47939569 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.46064414 |
| 63 | MP0004270_analgesia | 1.45971353 |
| 64 | MP0002067_abnormal_sensory_capabilities | 1.45760902 |
| 65 | MP0000767_abnormal_smooth_muscle | 1.43632892 |
| 66 | MP0001958_emphysema | 1.43068469 |
| 67 | MP0001502_abnormal_circadian_rhythm | 1.42967734 |
| 68 | MP0001905_abnormal_dopamine_level | 1.41584177 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.41113227 |
| 70 | MP0000749_muscle_degeneration | 1.39156637 |
| 71 | MP0003075_altered_response_to | 1.36460168 |
| 72 | MP0002909_abnormal_adrenal_gland | 1.35657713 |
| 73 | MP0004036_abnormal_muscle_relaxation | 1.35319432 |
| 74 | MP0004185_abnormal_adipocyte_glucose | 1.34730655 |
| 75 | MP0002822_catalepsy | 1.34299120 |
| 76 | MP0004145_abnormal_muscle_electrophysio | 1.33953830 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.31876709 |
| 78 | MP0002736_abnormal_nociception_after | 1.31373992 |
| 79 | MP0001851_eye_inflammation | 1.30922171 |
| 80 | MP0005464_abnormal_platelet_physiology | 1.30138263 |
| 81 | MP0001835_abnormal_antigen_presentation | 1.30107671 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 1.28825148 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.27794220 |
| 84 | MP0004924_abnormal_behavior | 1.27794220 |
| 85 | MP0008569_lethality_at_weaning | 1.27512808 |
| 86 | MP0003879_abnormal_hair_cell | 1.26399747 |
| 87 | MP0003091_abnormal_cell_migration | 1.24007065 |
| 88 | MP0005670_abnormal_white_adipose | 1.22273551 |
| 89 | MP0009278_abnormal_bone_marrow | 1.19758829 |
| 90 | MP0004859_abnormal_synaptic_plasticity | 1.19139713 |
| 91 | MP0002102_abnormal_ear_morphology | 1.18708471 |
| 92 | MP0005000_abnormal_immune_tolerance | 1.17973578 |
| 93 | MP0003137_abnormal_impulse_conducting | 1.16260798 |
| 94 | MP0010368_abnormal_lymphatic_system | 1.16222802 |
| 95 | MP0000920_abnormal_myelination | 1.15673938 |
| 96 | MP0004133_heterotaxia | 1.14933816 |
| 97 | MP0008877_abnormal_DNA_methylation | 1.14839631 |
| 98 | MP0000751_myopathy | 1.13802491 |
| 99 | MP0003634_abnormal_glial_cell | 1.13421708 |
| 100 | MP0001299_abnormal_eye_distance/ | 1.13232028 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 1.12282479 |
| 102 | MP0001963_abnormal_hearing_physiology | 1.12160423 |
| 103 | MP0005623_abnormal_meninges_morphology | 1.10845288 |
| 104 | MP0010329_abnormal_lipoprotein_level | 1.10055226 |
| 105 | MP0004484_altered_response_of | 1.07974665 |
| 106 | MP0004130_abnormal_muscle_cell | 1.07703556 |
| 107 | MP0003011_delayed_dark_adaptation | 1.07256453 |
| 108 | MP0000230_abnormal_systemic_arterial | 1.06171712 |
| 109 | MP0002166_altered_tumor_susceptibility | 1.05744700 |
| 110 | MP0005253_abnormal_eye_physiology | 1.05707413 |
| 111 | MP0008775_abnormal_heart_ventricle | 1.04954980 |
| 112 | MP0000604_amyloidosis | 1.03623304 |
| 113 | MP0002229_neurodegeneration | 1.02631526 |
| 114 | MP0003631_nervous_system_phenotype | 1.02072364 |
| 115 | MP0002972_abnormal_cardiac_muscle | 1.01333548 |
| 116 | MP0003122_maternal_imprinting | 1.00513297 |
| 117 | MP0002452_abnormal_antigen_presenting | 1.00138745 |
| 118 | MP0004272_abnormal_basement_membrane | 0.99612191 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.99146317 |
| 120 | MP0000778_abnormal_nervous_system | 0.98822819 |
| 121 | MP0003448_altered_tumor_morphology | 0.96823626 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.94507621 |
| 123 | MP0001790_abnormal_immune_system | 0.94383471 |
| 124 | MP0005387_immune_system_phenotype | 0.94383471 |
| 125 | MP0002837_dystrophic_cardiac_calcinosis | 0.94215948 |
| 126 | MP0005448_abnormal_energy_balance | 0.94091125 |
| 127 | MP0001879_abnormal_lymphatic_vessel | 0.93500388 |
| 128 | MP0002295_abnormal_pulmonary_circulatio | 0.93181744 |
| 129 | MP0005390_skeleton_phenotype | 0.92947365 |
| 130 | MP0005275_abnormal_skin_tensile | 0.92785124 |
| 131 | MP0005503_abnormal_tendon_morphology | 0.91741424 |
| 132 | MP0006072_abnormal_retinal_apoptosis | 0.91458454 |
| 133 | MP0000750_abnormal_muscle_regeneration | 0.91330711 |
| 134 | MP0005166_decreased_susceptibility_to | 0.89833835 |
| 135 | MP0002693_abnormal_pancreas_physiology | 0.88970941 |
| 136 | MP0001756_abnormal_urination | 0.88404959 |
| 137 | MP0002882_abnormal_neuron_morphology | 0.87891614 |
| 138 | MP0002066_abnormal_motor_capabilities/c | 0.87809576 |
| 139 | MP0004085_abnormal_heartbeat | 0.86213829 |
| 140 | MP0000026_abnormal_inner_ear | 0.84896133 |
| 141 | MP0009780_abnormal_chondrocyte_physiolo | 0.84757422 |
| 142 | MP0003633_abnormal_nervous_system | 0.84299079 |
| 143 | MP0005197_abnormal_uvea_morphology | 0.83787371 |
| 144 | MP0005535_abnormal_body_temperature | 0.83707296 |
| 145 | MP0002064_seizures | 0.83007276 |
| 146 | MP0003329_amyloid_beta_deposits | 0.82949965 |
| 147 | MP0009840_abnormal_foam_cell | 0.81838786 |
| 148 | MP0005076_abnormal_cell_differentiation | 0.81823487 |
| 149 | MP0009046_muscle_twitch | 0.81302684 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.79966887 |
| 151 | MP0004087_abnormal_muscle_fiber | 0.79737626 |
| 152 | MP0009384_cardiac_valve_regurgitation | 0.79727284 |
| 153 | MP0003724_increased_susceptibility_to | 0.79298802 |
| 154 | MP0005025_abnormal_response_to | 0.78898242 |
| 155 | MP0002928_abnormal_bile_duct | 0.78524105 |
| 156 | MP0002723_abnormal_immune_serum | 0.77904461 |
| 157 | MP0009764_decreased_sensitivity_to | 0.77780734 |
| 158 | MP0005377_hearing/vestibular/ear_phenot | 0.76269018 |
| 159 | MP0003878_abnormal_ear_physiology | 0.76269018 |
| 160 | MP0004233_abnormal_muscle_weight | 0.76211532 |
| 161 | MP0004019_abnormal_vitamin_homeostasis | 0.75927580 |
| 162 | MP0000733_abnormal_muscle_development | 0.75787434 |
| 163 | MP0005375_adipose_tissue_phenotype | 0.73997761 |
| 164 | MP0005165_increased_susceptibility_to | 0.73492671 |
| 165 | MP0002896_abnormal_bone_mineralization | 0.72842886 |
| 166 | MP0000465_gastrointestinal_hemorrhage | 0.72496999 |
| 167 | MP0002277_abnormal_respiratory_mucosa | 0.71901550 |
| 168 | MP0005595_abnormal_vascular_smooth | 0.71815064 |
| 169 | MP0002933_joint_inflammation | 0.71632179 |
| 170 | MP0010630_abnormal_cardiac_muscle | 0.71584867 |
| 171 | MP0001944_abnormal_pancreas_morphology | 0.70911582 |
| 172 | MP0005647_abnormal_sex_gland | 0.70458472 |
| 173 | MP0005330_cardiomyopathy | 0.70284817 |
| 174 | MP0002108_abnormal_muscle_morphology | 0.70157636 |
| 175 | MP0000955_abnormal_spinal_cord | 0.69945423 |
| 176 | MP0000249_abnormal_blood_vessel | 0.69640997 |
| 177 | MP0004215_abnormal_myocardial_fiber | 0.69603823 |
| 178 | MP0002078_abnormal_glucose_homeostasis | 0.68243832 |
| 179 | MP0003953_abnormal_hormone_level | 0.67862964 |
| 180 | MP0005620_abnormal_muscle_contractility | 0.66255256 |
| 181 | MP0001819_abnormal_immune_cell | 0.65766888 |
| 182 | MP0004134_abnormal_chest_morphology | 0.65725798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.28014190 |
| 2 | Dysostosis multiplex (HP:0000943) | 4.75736898 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.55797061 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.37481567 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.30702303 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.02630907 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.97477025 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.97477025 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.97477025 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.87444949 |
| 11 | Focal motor seizures (HP:0011153) | 3.82544222 |
| 12 | Febrile seizures (HP:0002373) | 3.80659871 |
| 13 | Cerebral aneurysm (HP:0004944) | 3.79152867 |
| 14 | Arterial tortuosity (HP:0005116) | 3.65196553 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.53795841 |
| 16 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.53795841 |
| 17 | Focal seizures (HP:0007359) | 3.46346725 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.46217826 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.46217826 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.46217826 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.45732268 |
| 22 | Glomerulonephritis (HP:0000099) | 3.35990706 |
| 23 | Atonic seizures (HP:0010819) | 3.33720939 |
| 24 | Vascular tortuosity (HP:0004948) | 3.33479404 |
| 25 | Hyperventilation (HP:0002883) | 3.32598954 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.31729801 |
| 27 | Hemiparesis (HP:0001269) | 3.24730828 |
| 28 | Pancreatic fibrosis (HP:0100732) | 3.17402458 |
| 29 | Aortic aneurysm (HP:0004942) | 3.13826290 |
| 30 | Axonal loss (HP:0003447) | 3.12964598 |
| 31 | Disinhibition (HP:0000734) | 3.11395828 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.09070259 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 3.09046232 |
| 34 | Decreased circulating renin level (HP:0003351) | 2.93674148 |
| 35 | Pancreatic cysts (HP:0001737) | 2.92221095 |
| 36 | Hematochezia (HP:0002573) | 2.92003346 |
| 37 | Abnormal drinking behavior (HP:0030082) | 2.90542264 |
| 38 | Polydipsia (HP:0001959) | 2.90542264 |
| 39 | Abnormality of midbrain morphology (HP:0002418) | 2.89279372 |
| 40 | Molar tooth sign on MRI (HP:0002419) | 2.89279372 |
| 41 | Retinal atrophy (HP:0001105) | 2.88246674 |
| 42 | True hermaphroditism (HP:0010459) | 2.83808262 |
| 43 | Aortic dissection (HP:0002647) | 2.80914407 |
| 44 | Large for gestational age (HP:0001520) | 2.79447381 |
| 45 | Spondylolisthesis (HP:0003302) | 2.79184379 |
| 46 | Genetic anticipation (HP:0003743) | 2.78895686 |
| 47 | Abolished electroretinogram (ERG) (HP:0000550) | 2.77005498 |
| 48 | Myokymia (HP:0002411) | 2.74694066 |
| 49 | Dialeptic seizures (HP:0011146) | 2.74567363 |
| 50 | Nephronophthisis (HP:0000090) | 2.74467212 |
| 51 | Type II lissencephaly (HP:0007260) | 2.71674613 |
| 52 | Limb dystonia (HP:0002451) | 2.66059666 |
| 53 | Medial flaring of the eyebrow (HP:0010747) | 2.64239483 |
| 54 | Asymmetric septal hypertrophy (HP:0001670) | 2.63984464 |
| 55 | Thick nail (HP:0001805) | 2.59823117 |
| 56 | Absence seizures (HP:0002121) | 2.54004300 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.53909409 |
| 58 | Mutism (HP:0002300) | 2.49494588 |
| 59 | Prolonged QT interval (HP:0001657) | 2.48636306 |
| 60 | Neuronal loss in central nervous system (HP:0002529) | 2.46573741 |
| 61 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.42595307 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.42244207 |
| 63 | Abnormality of the renal medulla (HP:0100957) | 2.41189764 |
| 64 | Cystic liver disease (HP:0006706) | 2.38608912 |
| 65 | Loss of speech (HP:0002371) | 2.38345672 |
| 66 | Abnormality of the renal cortex (HP:0011035) | 2.36175477 |
| 67 | Metabolic alkalosis (HP:0200114) | 2.35991626 |
| 68 | Generalized tonic-clonic seizures (HP:0002069) | 2.33755791 |
| 69 | Epileptic encephalopathy (HP:0200134) | 2.32885489 |
| 70 | Polyuria (HP:0000103) | 2.32336636 |
| 71 | Broad-based gait (HP:0002136) | 2.32011255 |
| 72 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.30803638 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28964197 |
| 74 | Inability to walk (HP:0002540) | 2.27065799 |
| 75 | Premature rupture of membranes (HP:0001788) | 2.26793483 |
| 76 | Abnormal eating behavior (HP:0100738) | 2.25706271 |
| 77 | Striae distensae (HP:0001065) | 2.24779863 |
| 78 | Gait imbalance (HP:0002141) | 2.24561587 |
| 79 | Scapular winging (HP:0003691) | 2.24194595 |
| 80 | Papilledema (HP:0001085) | 2.21193962 |
| 81 | Urethral obstruction (HP:0000796) | 2.20646419 |
| 82 | Polyphagia (HP:0002591) | 2.19308488 |
| 83 | Stomach cancer (HP:0012126) | 2.19079843 |
| 84 | Attenuation of retinal blood vessels (HP:0007843) | 2.18124549 |
| 85 | Congenital sensorineural hearing impairment (HP:0008527) | 2.17106374 |
| 86 | Inappropriate behavior (HP:0000719) | 2.16361774 |
| 87 | Abnormal EKG (HP:0003115) | 2.16353386 |
| 88 | Epileptiform EEG discharges (HP:0011182) | 2.14071865 |
| 89 | Abnormal urine output (HP:0012590) | 2.12366421 |
| 90 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.12026010 |
| 91 | Absent/shortened dynein arms (HP:0200106) | 2.12026010 |
| 92 | Abnormality of renin-angiotensin system (HP:0000847) | 2.11444080 |
| 93 | Aneurysm (HP:0002617) | 2.10770242 |
| 94 | Vertebral compression fractures (HP:0002953) | 2.10653170 |
| 95 | Disproportionate tall stature (HP:0001519) | 2.10221562 |
| 96 | Absent speech (HP:0001344) | 2.08614485 |
| 97 | Hypomagnesemia (HP:0002917) | 2.08024868 |
| 98 | Gingivitis (HP:0000230) | 2.07626919 |
| 99 | Thoracic kyphosis (HP:0002942) | 2.06841716 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06689724 |
| 101 | Progressive visual loss (HP:0000529) | 2.04983528 |
| 102 | Decreased central vision (HP:0007663) | 2.04450886 |
| 103 | Increased circulating renin level (HP:0000848) | 2.04055623 |
| 104 | Neurofibrillary tangles (HP:0002185) | 2.03297124 |
| 105 | J-shaped sella turcica (HP:0002680) | 2.02615837 |
| 106 | Shallow orbits (HP:0000586) | 2.01950098 |
| 107 | Increased corneal curvature (HP:0100692) | 2.01823882 |
| 108 | Keratoconus (HP:0000563) | 2.01823882 |
| 109 | Pathologic fracture (HP:0002756) | 2.01539008 |
| 110 | EEG with generalized epileptiform discharges (HP:0011198) | 2.01090465 |
| 111 | Chronic hepatic failure (HP:0100626) | 2.00585884 |
| 112 | Nephritis (HP:0000123) | 1.99160129 |
| 113 | Syncope (HP:0001279) | 1.95101022 |
| 114 | Hypsarrhythmia (HP:0002521) | 1.94710557 |
| 115 | Anxiety (HP:0000739) | 1.93978237 |
| 116 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.93609356 |
| 117 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.93609356 |
| 118 | Congenital primary aphakia (HP:0007707) | 1.92531692 |
| 119 | Mitral valve prolapse (HP:0001634) | 1.91503944 |
| 120 | Ventricular fibrillation (HP:0001663) | 1.91177942 |
| 121 | Tubular atrophy (HP:0000092) | 1.89637409 |
| 122 | Bone pain (HP:0002653) | 1.89227011 |
| 123 | Abnormality of renal excretion (HP:0011036) | 1.88557476 |
| 124 | Postural instability (HP:0002172) | 1.88258313 |
| 125 | Status epilepticus (HP:0002133) | 1.88236165 |
| 126 | Hypothermia (HP:0002045) | 1.88189729 |
| 127 | Ketoacidosis (HP:0001993) | 1.87738434 |
| 128 | Progressive inability to walk (HP:0002505) | 1.87368972 |
| 129 | Protrusio acetabuli (HP:0003179) | 1.86354758 |
| 130 | Genital tract atresia (HP:0001827) | 1.85715644 |
| 131 | Protruding tongue (HP:0010808) | 1.85107297 |
| 132 | Fair hair (HP:0002286) | 1.85004450 |
| 133 | Widely spaced teeth (HP:0000687) | 1.84782682 |
| 134 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.84553360 |
| 135 | Recurrent skin infections (HP:0001581) | 1.83848372 |
| 136 | Apathy (HP:0000741) | 1.83519152 |
| 137 | Agitation (HP:0000713) | 1.82711417 |
| 138 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.82467522 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.82191864 |
| 140 | Broad metatarsal (HP:0001783) | 1.81525621 |
| 141 | Left ventricular hypertrophy (HP:0001712) | 1.79764371 |
| 142 | Hypokalemic alkalosis (HP:0001949) | 1.79444590 |
| 143 | Ulnar claw (HP:0001178) | 1.78631354 |
| 144 | Rapidly progressive (HP:0003678) | 1.77572621 |
| 145 | Furrowed tongue (HP:0000221) | 1.77279133 |
| 146 | Stomatitis (HP:0010280) | 1.77055300 |
| 147 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.76923228 |
| 148 | Hypoplasia of the fovea (HP:0007750) | 1.76923228 |
| 149 | Increased CSF protein (HP:0002922) | 1.76082875 |
| 150 | Hyperlipoproteinemia (HP:0010980) | 1.75912372 |
| 151 | Coarse hair (HP:0002208) | 1.75457529 |
| 152 | Hemiplegia (HP:0002301) | 1.75340001 |
| 153 | Complement deficiency (HP:0004431) | 1.75082837 |
| 154 | Ovoid vertebral bodies (HP:0003300) | 1.74376202 |
| 155 | Clumsiness (HP:0002312) | 1.72122791 |
| 156 | Abnormal ciliary motility (HP:0012262) | 1.72098775 |
| 157 | Abnormality of the sella turcica (HP:0002679) | 1.71071739 |
| 158 | Abnormality of the thoracic spine (HP:0100711) | 1.69851267 |
| 159 | Atrial fibrillation (HP:0005110) | 1.69454863 |
| 160 | Hyperaldosteronism (HP:0000859) | 1.69249825 |
| 161 | Action tremor (HP:0002345) | 1.69120536 |
| 162 | Vaginal atresia (HP:0000148) | 1.69049227 |
| 163 | Diminished motivation (HP:0000745) | 1.68008398 |
| 164 | Nephrogenic diabetes insipidus (HP:0009806) | 1.67339194 |
| 165 | Peripheral demyelination (HP:0011096) | 1.66969945 |
| 166 | Abnormality of the calf musculature (HP:0001430) | 1.66612530 |
| 167 | Exotropia (HP:0000577) | 1.63815507 |
| 168 | Joint stiffness (HP:0001387) | 1.62287357 |
| 169 | Myocardial infarction (HP:0001658) | 1.60812642 |
| 170 | Hand muscle atrophy (HP:0009130) | 1.60208484 |
| 171 | Upper limb amyotrophy (HP:0009129) | 1.59779902 |
| 172 | Distal upper limb amyotrophy (HP:0007149) | 1.59779902 |
| 173 | Progressive neurologic deterioration (HP:0002344) | 1.58366945 |
| 174 | Cerebral inclusion bodies (HP:0100314) | 1.57637060 |
| 175 | Facial diplegia (HP:0001349) | 1.57615509 |
| 176 | Abnormality of the lumbar spine (HP:0100712) | 1.57239897 |
| 177 | Broad ribs (HP:0000885) | 1.56971941 |
| 178 | Dilatation of the ascending aorta (HP:0005111) | 1.56437930 |
| 179 | Macroorchidism (HP:0000053) | 1.56387019 |
| 180 | Pulmonary artery stenosis (HP:0004415) | 1.56109486 |
| 181 | Abnormality of complement system (HP:0005339) | 1.55457512 |
| 182 | Hypoplasia of the odontoid process (HP:0003311) | 1.55176893 |
| 183 | Abnormality of the odontoid process (HP:0003310) | 1.54923676 |
| 184 | Dementia (HP:0000726) | 1.53795673 |
| 185 | Hypoplastic ischia (HP:0003175) | 1.53770550 |
| 186 | Tetraparesis (HP:0002273) | 1.53528249 |
| 187 | Abnormality of binocular vision (HP:0011514) | 1.52145667 |
| 188 | Diplopia (HP:0000651) | 1.52145667 |
| 189 | Primary atrial arrhythmia (HP:0001692) | 1.51652490 |
| 190 | Chronic obstructive pulmonary disease (HP:0006510) | 1.51441245 |
| 191 | Obstructive lung disease (HP:0006536) | 1.51441245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.71275716 |
| 2 | CAMK1G | 2.62596351 |
| 3 | CAMK1D | 2.56249646 |
| 4 | NTRK3 | 2.54415585 |
| 5 | PINK1 | 2.51465896 |
| 6 | ERN1 | 2.47909622 |
| 7 | RIPK4 | 2.41078276 |
| 8 | TAOK3 | 2.33600300 |
| 9 | TRIB3 | 2.25434216 |
| 10 | ADRBK2 | 2.17099215 |
| 11 | EPHB1 | 2.16220179 |
| 12 | BLK | 2.14058843 |
| 13 | BMPR1B | 2.09972566 |
| 14 | DMPK | 2.00985552 |
| 15 | WNK4 | 1.99485180 |
| 16 | RIPK1 | 1.92502018 |
| 17 | TTN | 1.91380623 |
| 18 | FES | 1.86498188 |
| 19 | CAMKK2 | 1.83027397 |
| 20 | CASK | 1.82430640 |
| 21 | INSRR | 1.80168441 |
| 22 | PKN2 | 1.78083360 |
| 23 | WNK3 | 1.74956990 |
| 24 | FGFR2 | 1.74204890 |
| 25 | NTRK2 | 1.68086446 |
| 26 | ACVR1B | 1.67469793 |
| 27 | GRK1 | 1.66397023 |
| 28 | CSF1R | 1.61346539 |
| 29 | EPHA4 | 1.59900630 |
| 30 | SIK1 | 1.57184814 |
| 31 | JAK1 | 1.56370766 |
| 32 | TXK | 1.54935441 |
| 33 | IRAK4 | 1.54193431 |
| 34 | MAP4K2 | 1.51858700 |
| 35 | MARK1 | 1.50131248 |
| 36 | CAMKK1 | 1.44718412 |
| 37 | MAPK13 | 1.41753745 |
| 38 | NTRK1 | 1.37886304 |
| 39 | AKT3 | 1.36446367 |
| 40 | KIT | 1.35493897 |
| 41 | LATS1 | 1.34690381 |
| 42 | MAPK15 | 1.34564236 |
| 43 | MAP3K4 | 1.32473876 |
| 44 | PTK6 | 1.31211816 |
| 45 | GRK7 | 1.27517954 |
| 46 | IRAK3 | 1.26410515 |
| 47 | PAK3 | 1.24792735 |
| 48 | PAK4 | 1.18302623 |
| 49 | SIK2 | 1.18133199 |
| 50 | PRKCG | 1.16792286 |
| 51 | TBK1 | 1.16336125 |
| 52 | TYK2 | 1.14205704 |
| 53 | PNCK | 1.08268883 |
| 54 | PTK2 | 1.05784544 |
| 55 | OXSR1 | 1.03542231 |
| 56 | UHMK1 | 0.98661157 |
| 57 | ADRBK1 | 0.98521583 |
| 58 | TNIK | 0.97790594 |
| 59 | STK39 | 0.97122063 |
| 60 | SGK494 | 0.96146571 |
| 61 | SGK223 | 0.96146571 |
| 62 | MAP3K7 | 0.95545806 |
| 63 | NLK | 0.95537319 |
| 64 | WNK1 | 0.94587959 |
| 65 | TYRO3 | 0.94401461 |
| 66 | GRK5 | 0.92211693 |
| 67 | HCK | 0.91863315 |
| 68 | PDPK1 | 0.91429525 |
| 69 | CSK | 0.90201877 |
| 70 | RET | 0.89790527 |
| 71 | FGR | 0.88187381 |
| 72 | KDR | 0.87942881 |
| 73 | PTK2B | 0.84287943 |
| 74 | MAP3K13 | 0.84173933 |
| 75 | PAK6 | 0.82067437 |
| 76 | FRK | 0.80803586 |
| 77 | ITK | 0.79602559 |
| 78 | CAMK2A | 0.79515232 |
| 79 | PDGFRB | 0.78981390 |
| 80 | PRKD1 | 0.78641089 |
| 81 | SCYL2 | 0.78119121 |
| 82 | NEK9 | 0.78071677 |
| 83 | PRKCH | 0.77670081 |
| 84 | MAP2K3 | 0.77354089 |
| 85 | IRAK2 | 0.77116497 |
| 86 | IRAK1 | 0.74756771 |
| 87 | PDK1 | 0.74095751 |
| 88 | PDGFRA | 0.74001715 |
| 89 | PRKCQ | 0.73538123 |
| 90 | JAK2 | 0.73437973 |
| 91 | MAP3K2 | 0.71878997 |
| 92 | DAPK2 | 0.71305754 |
| 93 | NUAK1 | 0.70013200 |
| 94 | STK38 | 0.69548205 |
| 95 | MAP3K14 | 0.69458903 |
| 96 | MAPK12 | 0.68154397 |
| 97 | SGK3 | 0.67129147 |
| 98 | CAMK1 | 0.67025863 |
| 99 | CAMK4 | 0.66940982 |
| 100 | ICK | 0.66899823 |
| 101 | KSR2 | 0.65776874 |
| 102 | CDK8 | 0.64139309 |
| 103 | CAMK2B | 0.62881725 |
| 104 | DYRK1A | 0.62534725 |
| 105 | CDK5 | 0.62273647 |
| 106 | TRPM7 | 0.61694352 |
| 107 | PKN1 | 0.61621001 |
| 108 | CLK1 | 0.61125993 |
| 109 | PRKCZ | 0.60714727 |
| 110 | SGK1 | 0.60128233 |
| 111 | FYN | 0.59343131 |
| 112 | PRKG1 | 0.58778041 |
| 113 | TNK2 | 0.57704212 |
| 114 | SYK | 0.57386798 |
| 115 | DYRK2 | 0.57212532 |
| 116 | BMX | 0.56070588 |
| 117 | PIK3CG | 0.56025502 |
| 118 | FGFR3 | 0.55522067 |
| 119 | HIPK2 | 0.54091134 |
| 120 | MYLK | 0.53834253 |
| 121 | CAMK2D | 0.53674613 |
| 122 | PHKG2 | 0.53373978 |
| 123 | PHKG1 | 0.53373978 |
| 124 | PAK2 | 0.53161287 |
| 125 | RPS6KA2 | 0.53127444 |
| 126 | LMTK2 | 0.52867916 |
| 127 | SRC | 0.51808413 |
| 128 | LCK | 0.51089730 |
| 129 | MAP2K6 | 0.51048466 |
| 130 | STK11 | 0.50569575 |
| 131 | ROCK1 | 0.50128730 |
| 132 | SGK2 | 0.49949436 |
| 133 | MAP4K1 | 0.49688901 |
| 134 | PRKACA | 0.49523745 |
| 135 | TIE1 | 0.49296301 |
| 136 | MAP3K9 | 0.49262713 |
| 137 | PLK2 | 0.48823368 |
| 138 | TGFBR1 | 0.48707992 |
| 139 | MATK | 0.47935097 |
| 140 | MOS | 0.47844465 |
| 141 | TAOK1 | 0.47307743 |
| 142 | MARK2 | 0.46553065 |
| 143 | ZAP70 | 0.46512961 |
| 144 | PRKD2 | 0.46482214 |
| 145 | PIK3CA | 0.46016336 |
| 146 | MAPK7 | 0.45876599 |
| 147 | IKBKB | 0.45725107 |
| 148 | PRKD3 | 0.45498616 |
| 149 | JAK3 | 0.45246354 |
| 150 | EPHA3 | 0.44535417 |
| 151 | MAP2K1 | 0.44404123 |
| 152 | PRKCE | 0.44070683 |
| 153 | FER | 0.43867244 |
| 154 | PRKAA2 | 0.43764949 |
| 155 | LYN | 0.43711056 |
| 156 | PRKCA | 0.42807451 |
| 157 | GRK6 | 0.41741665 |
| 158 | STK38L | 0.41388527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.74553306 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.44826122 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39668456 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.37402967 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.20666152 |
| 6 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.97039332 |
| 7 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.95609683 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.89900015 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.88400522 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.76584093 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74921979 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70396402 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.69443774 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.67299335 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.62492613 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56024438 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55097101 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51162866 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.49405048 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44133697 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.42137111 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36555743 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32672006 |
| 24 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.31647762 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31321923 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.31306158 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29341724 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28512048 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26834676 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.24605429 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.24367490 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.21573023 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.20903965 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.19315881 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18490356 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18071756 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.17264182 |
| 38 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.16900008 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15976527 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11531434 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10661062 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.09674941 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.07552275 |
| 44 | Focal adhesion_Homo sapiens_hsa04510 | 1.06919578 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.06645789 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05675466 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05293273 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05219694 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.04450441 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04190891 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04173982 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 1.03807959 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.03652216 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03591596 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03565767 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02913795 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01848256 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98253081 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97479566 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.96480030 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.94155293 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93948990 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.93772297 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93698896 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 0.92110730 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91731250 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 0.91250391 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.90961906 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90736073 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90589692 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90212768 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90171283 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89768215 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89727601 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89457733 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88695226 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.88370097 |
| 78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.88232132 |
| 79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87670455 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.87442097 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86410274 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86244959 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85534382 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85412676 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85099823 |
| 86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83724619 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83686799 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83465309 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.82895572 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82837104 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82439081 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82181201 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.81025797 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79969233 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.78044700 |
| 96 | Long-term depression_Homo sapiens_hsa04730 | 0.77321785 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76293422 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76067158 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75480498 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75469324 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74340880 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74244716 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74127491 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73799947 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73485043 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73390663 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73149103 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72844373 |
| 109 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72820330 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71735567 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71497476 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71404415 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71259891 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70972909 |
| 115 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70371634 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70128715 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70101325 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70000328 |
| 119 | Adherens junction_Homo sapiens_hsa04520 | 0.69739868 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69555500 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68761573 |
| 122 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68426732 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68339908 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67589514 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.66729997 |
| 126 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65952893 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65924182 |
| 128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65394311 |
| 129 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.65318953 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64868254 |
| 131 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64269263 |
| 132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64253616 |
| 133 | Melanoma_Homo sapiens_hsa05218 | 0.63637310 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63113078 |
| 135 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63041374 |
| 136 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62408672 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62201913 |
| 138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61945698 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61296819 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60965675 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60739847 |
| 142 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60538030 |
| 143 | Shigellosis_Homo sapiens_hsa05131 | 0.60235305 |
| 144 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55750383 |
| 145 | Peroxisome_Homo sapiens_hsa04146 | 0.54612216 |
| 146 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54492389 |
| 147 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54104652 |
| 148 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52652497 |
| 149 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52144537 |
| 150 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48780187 |
| 151 | Axon guidance_Homo sapiens_hsa04360 | 0.44981128 |
| 152 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43087567 |
| 153 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42507234 |
| 154 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.41778155 |
| 155 | Melanogenesis_Homo sapiens_hsa04916 | 0.40009327 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38143963 |
| 157 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33959273 |
| 158 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33914531 |
| 159 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33790631 |
| 160 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33181709 |

